CompoAtlas

Flora Natura Mauve BIO gélules

Food supplement declared in France, decision dated 21 April 2025

Flora Natura Mauve BIO gélules, from Scientia Natura Distribution, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Malva sylvestris 2,040 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Flora Natura
Food business operator placing the product on the market
Scientia Natura Distribution
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3
Directions for use
Prendre 3 gélules par jour, le matin, le midi et le soir.
Intended populations
General population, Men and women aged 18 and over
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 259737, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Malva sylvestris L.Parties aériennesExtrait sec aqueux2,040 mg

Additives

E414

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Flora Natura

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Flora Natura Mauve BIO gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/259737-flora-natura-mauve-bio-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line